Clinical Trials Logo

Stage III Uveal Melanoma AJCC v7 clinical trials

View clinical trials related to Stage III Uveal Melanoma AJCC v7.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01835145 Completed - Clinical trials for Stage IV Uveal Melanoma AJCC v7

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Start date: July 31, 2013
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well cabozantinib-s-malate works compared with temozolomide or dacarbazine in treating patients with melanoma of the eye (ocular melanoma) that has spread to other parts of the body and cannot be removed by surgery. Cabozantinib-s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide and dacarbazine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether cabozantinib-s-malate works better than temozolomide or dacarbazine in treating patients with melanoma of the eye.